Understanding how tau protein spreads in Alzheimer's disease
Decoding Selective Vulnerability: Effectors and Regulators of Tau Lesion Spread in Alzheimer's Disease
This study is looking at how tau protein spreads in the brains of people with Alzheimer's disease to help us understand why some areas are more affected than others, which could lead to new ways to treat the condition.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10899770 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind the spread of tau protein lesions in Alzheimer's disease, which is a leading cause of dementia. By examining how tau tangles propagate through the brain and identifying regions that are vulnerable or resistant to this spread, the study aims to uncover the underlying biological processes. The approach involves analyzing gene expression responses in different brain areas to better understand the interactions that contribute to disease progression. This could lead to insights into potential therapeutic targets for Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk for developing it.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or slowing the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in understanding tau pathology in Alzheimer's, but this specific approach to studying selective vulnerability is relatively novel.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Ayoub, Christopher Anthony — Ohio State University
- Study coordinator: Ayoub, Christopher Anthony
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.